Zhejiang Hisun Pharmaceutical Hits Day Low Amid Price Pressure at CNY 11.30

Zhejiang Hisun Pharmaceutical Co., Ltd. experienced a notable decline today, with the stock dropping by 5.59% as it reached an intraday low of CNY 11.30. This performance contrasts with the broader market, as the China Shanghai Composite index fell by 3.05% on the same day. In terms of recent performance, Zhejiang Hisun has shown resilience over the past week, gaining 5.11%, while the one-month performance reflects a significant increase of 17.31%. However, the stock has faced challenges over the past year, with a decline of 10.58%, in stark contrast to the China Shanghai Composite's gain of 7.03%. Financial metrics indicate that the company maintains a market capitalization of CNY 10,432 million and a price-to-earnings ratio of 14.00. The return on equity stands at 8.20%, and the company boasts a low debt-to-equity ratio of 0.05, suggesting a stable financial position. Despite today's downturn, the stock's performance over the year-to-date remains positive, with a gain of 14.46%.